Skip to main content
Publications
Morris MJ, de Bono J, Nagarajah J, Sartor O, Wei XX, Nordquist LT, Koshkin VS, Chi KN, Krause BJ, Herrmann K, Rahbar K, Vickers A , Mirante O, Ghouse R, Fizazi K, Tagawa ST. Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: analysis of the phase 3 VISION trial . Cancer. 2024 Oct 15;130(20):3426-35. doi: 10.1002/cncr.35438
Duran CE, Riera-Arnau J, Abtahi S, Pajouheshnia R , Hoxhaj V, Gamba M, Alsina E, Martin-Perez M, Garcia-Posa P, Llorente-Garcia A, Gonzalez-Bermejo D, Ibanez L, Sabate M, Vidal X, Ballarin E, Sanfelix-Gimeno G, Rodriguez-Bernal C, Peiro S, Garcia-Sempere A, Sanchez-Saez F, Lentile V, Ingrasciotta Y, Guarneri C, Tanaglia M, Tari M, Herings R, Houben E, Swart-Polinder K, Holthuis E, Huerta C, Gini R, Roberto G, Bartolini C, Paoletti O, Limoncella G, Girardi A, Hyeraci G, Andersen M, Kristiansen SB, Hallgreen CE, Klungel O, Sturkenboom M. Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis . Front Pharmacol. 2023 Aug 17;14:1207976. doi: 10.3389/fphar.2023.1207976
Abdulkareem NM, Bhat R, Powell RT, Chikermane S, Yande S , Trinh L, Abdelnasser HY, Tabassum M, Ruiz A, Sobieski M, Nguyen ND, Johnson M, Kaipparettu BA, Johnson CA, Bond RA, Stephan C, Triveni MV. Screening of GPCR drugs for repurposing in breast cancer . Front Pharmacol. 2022 Dec 6;13:1049640. doi: 10.3389/fphar.2022.1049640
Lopez-Vicente M, Ribas Fito N, Vilor-Tejedor N, Garcia-Esteban R , Fernandez-Barres S, Dadvand P, Murcia M, Rebagliato M, Ibarluzea J, Lertxundi A, Fernandez-Somoano A, Tardon A, Lopez-Sabater MC, Romaguera D, Vrijheid M, Sunyer J, Julvez J. Prenatal omega-6:omega-3 ratio and attention deficit and hyperactivity disorder symptoms . J Pediatr. 2019 Jun;209:204-211.e. doi: 10.1016/j.jpeds.2019.02.022
Fernandez-Barres S, Vrijheid M, Manzano-Salgado CB, Valvi D, Martinez D , Iniguez C, Jimenez-Zabala A, Riano-Galan I, Navarrete-Munoz EM, Santa-Marina L, Tardon A, Vioque J, Arija V, Sunyer J, Romaguera D, Infancia y Medio Ambiente (INMA) Project. The association of Mediterranean Diet during pregnancy with longitudinal body mass index trajectories and cardiometabolic risk in early childhood . J Pediatr. 2019 Mar;206:119-27. doi: 10.1016/j.jpeds.2018.10.005
Ferrer M, Garcia-Esteban R , Iniguez C, Costa O, Fernandez-Somoano A, Rodríguez-Delhi C, Ibarluzea J, Lertxundi A, Tonne C, Sunyer J, Julvez J. Head circumference and child ADHD symptoms and cognitive functioning: results from a large population-based cohort study . Eur Child Adolesc Psychiatry. 2019 Mar;28(3):377-88. doi: 10.1007/s00787-018-1202-4
Lopez-Vicente M, Garcia-Aymerich J, Torrent-Pallicer J, Forns J , Ibarluzea J, Lertxundi N, Gonzalez L, Valera-Gran D, Torrent M, Dadvand P, Vrijheid M, Sunver J. Are early physical activity and sedentary behaviors related to working memory at 7 and 14 years of age? J Pediatr. 2017 Sep;188:35-41.e1. doi: 10.1016/j.jpeds.2017.05.079.
Hunter JE, Zepp JM, Gilmore MJ, Davis JV, Esterberg EJ , Muessig KR, Peterson SK, Syngal S, Acheson LS, Wiesner GL, Reiss JA, Goddard KA. Universal tumor screening for Lynch syndrome: assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers . Cancer. 2015 Sep 15;121(18):3281-9. doi: 10.1002/cncr.29470
Burris HA, Lebrun F, Rugo HS, Beck T, Piccart M, Neven P, Baselga J, Petrakova K, Hortobagyi GN, Komorowski A, Chouinard E, Young R, Gnant M, Pritchard KI, Bennett L , Ricci J-F, Bauly H, Taran T, Sahmoud T, Noguchi S. Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial . Cancer. 2013 Mar 15;119(10):1908-15.
Maurel J, Martins AS, Poveda A, Lopez-Guerrero JA, Cubedo R, Casado A, Martinez-Trufero J, Ramon Ayuso J, Lopez-Pousa A, Garcia-Albeniz X , Garcia del Muro X, de Alava E. Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib: a phase I-II study by the Spanish Group for Research on Sarcomas . Cancer. 2010 Aug 1;116(15):3692-701. doi: 10.1002/cncr.25111